Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
about
Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal TransitionCan anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressRole of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewExecutive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive agingFertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessmentAnti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsObesity and reproductive hormone levels in the transition to menopauseAnti-mullerian hormone as a predictor of time to menopause in late reproductive age womenLuteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight womenDoes accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?Factors that influence entry into stages of the menopausal transitionImpact of breast cancer on anti-mullerian hormone levels in young womenThe impact of smoking on antimüllerian hormone levels in women aged 38 to 50 yearsAssociation of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer RiskHigh-Fat Diet Causes Subfertility and Compromised Ovarian Function Independent of Obesity in Mice.Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivorsBody size affects measures of ovarian reserve in late reproductive age women.Antimullerian hormone and obesity: insights in oral contraceptive users.Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenismMaternal antimullerian hormone levels do not predict fetal aneuploidy.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.The physiology and clinical utility of anti-Mullerian hormone in women.Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females.The reproductive endocrinology of the menopausal transition.First assessment of menstrual cycle function and reproductive endocrine status in Samoan women.Animal age, weight and estrus cycle stage impact the quality of in vitro grown folliclesAnti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.Serum antimüllerian hormone in healthy premenopausal women.Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.Chronic Pelvic Inflammation Diminished Ovarian Reserve as Indicated by Serum Anti Mülerrian Hormone.Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian womenDynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.Preoperative serum anti-mullerian hormone level in women with ovarian endometrioma and mature cystic teratomaEarly Life Body Fatness, Serum Anti-Müllerian Hormone, and Breast Density in Young Adult Women.Effects of testosterone on the expression levels of AMH, VEGF and HIF-1α in mouse granulosa cellsIntrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertiliCan high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?Hormone changes associated with the menopausal transition.Anti-Müllerian hormone as a marker of ovarian reserve: an update.
P2860
Q26740255-7D9A6E01-73C0-4C17-91A9-BF6475C45E45Q26773554-52A7A949-2D41-4534-A438-08F5446D69F7Q26774060-CE8A25EB-A989-4078-A627-9F9AB9910B3AQ27026188-C98EAE61-63F8-48CB-8B8F-57A061399EE0Q28077710-AEE20262-9230-470C-85EE-5BD703098399Q28239980-ACDE5FE3-2FFA-4EB0-94CA-1680210772FBQ28275528-4FE65FAC-1441-49A8-ACE4-282322EF7CC3Q28383911-1B87E2B5-0587-4023-BC44-568538EA7586Q28391267-ED732ED7-538A-4E86-BD89-7C04355CE024Q28391817-D6523E3E-FBE3-40E4-8E9D-A1BBCE1F3FC4Q28392237-9EABD3D3-8D55-448F-8A25-F5170C5C5DC5Q28392860-4BC25321-643E-462D-A008-30E7C51C41C5Q28395441-B3DA8DE7-170F-410D-BBA9-B44DCD1A02B6Q28396126-E3C45EBE-058D-444E-B3EA-B13DD60840BBQ30352922-FE2BDD69-A1C6-4149-936E-002CF0482881Q33624886-A522568F-045F-422F-87FF-C05726D5D889Q33653083-02773657-242D-48A3-B174-251F4F3C9FC0Q33669042-2C177E3B-264B-42AC-BA31-74CF9589D6E8Q33786859-63488CC2-BFAA-4D35-9D30-21163E73FA09Q34070204-AC0523EF-3B0C-4B89-A0F3-33D9A85E2AAFQ34255040-FD062974-388B-44A2-8228-4C49DE45869AQ34398233-97942BC4-AE76-41F8-B2E6-CAF6FDD8AB36Q34769332-FE06423A-3F3E-4B99-8FDE-C5FAE73680A1Q35000332-89CCD902-4D02-492D-90E4-02A87A1B7CF9Q35169303-40772A8A-A4A4-44A8-934E-7FCEE788C2B8Q35169310-41AE1BE7-CC37-48AD-AF63-30D971DC8AB0Q35181958-134F8CFC-24DB-4449-B097-DB020855945AQ35185385-EA7A69B0-A168-446A-90A5-223D13F25875Q35898934-BCF966B4-DC1D-4F3C-8B66-94D29E56153DQ35924430-A6B8D45B-9D5D-4FD0-AE46-6BE56AFAD1E3Q36043997-A7437EE8-67D3-493C-B6C5-08EC97D8D1ECQ36127723-EC054513-5899-4EBD-9EE8-2CB4BF960A75Q36282786-30B23749-B73A-41F5-B250-78BC9DFB1A71Q36872935-C0DAF818-89B0-4310-B7D4-839D50983333Q37059875-B61320DF-8875-4C09-9C87-80701F242ABEQ37108532-E3D61046-2DD1-4D39-8C79-C28694D95E52Q37245167-28D79A1F-5EBD-4257-9164-419A6D4577DFQ37264532-0483FEB0-7DB5-4551-AB6B-2C8CCFA668D8Q37297638-EC04CCE3-45A3-428D-8314-5A280F691105Q37346173-E3EC44C9-DB01-498F-AF32-BE074415D118
P2860
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@en
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@nl
type
label
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@en
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@nl
prefLabel
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@en
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@nl
P2093
P1476
Association of anti-mullerian hormone levels with obesity in late reproductive-age women.
@en
P2093
Clarisa R Gracia
Ellen W Freeman
Jerome F Strauss
Lony Chong-Leong Lim
Mary D Sammel
P304
P356
10.1016/J.FERTNSTERT.2006.05.074
P407
P577
2006-11-15T00:00:00Z